TMO
Thermo Fisher Scientific Inc. · Healthcare · Medical - Diagnostics & Research
动量输入（同类管理人）：
持有人广度 -8.7% ·
股份流向 -0.7% ·
净新建仓位 -9.5%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 191 | +3 | 260.72M | $131.51B | +5 | −1 |
| Q1 2026 | 190 | +2 | 255.88M | $126.62B | +7 | −6 |
| Q4 2025 | 187 | +3 | 274.75M | $159.19B | +4 | — |
| Q3 2025 | 29 | -1 | 154.46M | $74.90B | +1 | −3 |
| Q2 2025 | 28 | +3 | 123.95M | $50.25B | +3 | — |
| Q1 2025 | 22 | -2 | 60.64M | $30.17B | — | −2 |
| Q4 2024 | 24 | +2 | 61.50M | $31.99B | +2 | — |
| Q3 2024 | 21 | -2 | 44.46M | $27.48B | — | −2 |
| Q2 2024 | 23 | — | 44.78M | $24.75B | — | — |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 10.97M | +10.6% | $6.79B | 0.8% | ▲ Add | 2 | SEC ↗ ×2 |
| 2 | Capital World Investors ✦ | 9.33M | -2.0% | $5.77B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 7.66M | +1.7% | $4.72B | 0.4% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (被动) | 5.59M | +0.4% | $3.46B | 0.5% | ▲ Add | 2 | SEC ↗ |
| 5 | Fisher Asset Management ✦ | 2.64M | +2.5% | $1.63B | 0.7% | ▲ Add | 2 | SEC ↗ |
| 6 | PRIMECAP Management ✦ | 2.57M | -3.5% | $1.59B | 1.2% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ ×8 |
| 8 | Marshall Wace ✦ | 627.73K | +89576.1% | $388.30M | 0.5% | ▲ Add | 2 | SEC ↗ ×3 |
| 9 | Baillie Gifford ✦ | 603.39K | -2.9% | $373.24M | 0.3% | ▼ Trim | 2 | SEC ↗ ×4 |
| 10 | Two Sigma Investments ✦ | 397.23K | -7.2% | $245.71M | 0.6% | ▼ Trim | 2 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 357.72K | +1.6% | $221.28M | 0.4% | ▲ Add | 2 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 337.85K | +67.9% | $208.98M | 0.3% | ▲ Add | 2 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 211.41K | +115.4% | $129.35M | 0.2% | ▲ Add | 2 | SEC ↗ ×4 |
| 14 | Arrowstreet Capital ✦ | 206.32K | +588.9% | $127.63M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 166.19K | -83.1% | $102.80M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 16 | Millennium Management ✦ | 122.48K | -78.3% | $75.76M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 48.95K | -79.2% | $30.28M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Markel Group ✦ | 35.40K | +20.4% | $21.90M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 19 | Dodge & Cox ✦ | 26.77K | -0.1% | $16.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 23.41K | +10.0% | $14.48M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 21 | GAMCO Investors ✦ | 4.28K | -0.2% | $2.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Point72 Asset Management | $186.10M | 曾为 0.6% |
| Bridgewater Associates | $18.65M | 曾为 0.1% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 24.30K 股份, $11,944 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer · 3.73K 股 · $2.29M
Officer · 400 股 · $245,752
Officer, Director · 62 股 · $38,982
Officer, Director · 33 股 · $20,677
Officer, Director · 101 股 · $63,166
Officer, Director · 79 股 · $49,613
Officer, Director · 2.15K 股 · $1.35M
Officer, Director · 1.79K 股 · $1.12M
Officer, Director · 3.01K 股 · $1.89M
Officer, Director · 2.73K 股 · $1.71M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论